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promised patient confidentiality, as it allowed identi- 
fication of these individuals. The significant differences 
in practice prompted a survey of 11 other hospitals 
within the Yorkshire region, which revealed that these 
disparities were not confined to our organisation. CBW 
was rejected on grounds of preparation time, staff safety 
and patient confidentiality. Non-carbonated bottled 
water was rejected because of poor microbiological 
quality. Carbonated water, although microbiologically 
safer, was not acceptable to patients with chemotherapy- 
associated mucositis. SBW, as with other bottled water 
types, was relatively expensive and had poor organo- 
leptic quality. There were also logistical problems in 
delivery to, and storage of bottles on, units citywide. FW 
met criteria 1 to 3 and compared favourably with bottled 
water in terms of cost. FW has now been accepted as the 
preferred method of providing water to IC patients in 
our organisation 
Conclusion: Striking disparities in provision of potable 
water for IC patients as identified locally and regionally 
are of concern and we recommend that national 
guidelines are developed to ensure that IC patients 
receive safe drinking water. We would advocate that 
consideration should be given to filtered water in the 
drawing up of such guidelines 
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Objectives: Bacteremia due to Escherichia coli (ECB) is 
still the most common causes of infection in patients 
with hematologic malignancies in our center. 
Methods: The clinical characteristics of ECB in 2001 
were evaluated retrospectively. The results were com- 
pared with a control group with vancomycin resistant 
enterococci bacteremia (VREB). 
Results: Total 85 patients experienced the ECB in 
the year of 2001. Age, sex ratio, SAPS11 score were 
not different statistically from each other group. The 
Underlying diseases in ECB were acute myloid leu- 
kemia (AML) (63.5%) acute lymphoblastic leukemia 
(ALL) (34.1%) and the type of therapy were induction 
or reinduction chemotherapy(37.7%), consolidation 
chemotherapy (35.3%) allogeneic bone marrow trans- 
plant (BMT) (13.0%) autologous BMT (10.6%). The 
underlying diseases and type of therapy were different 
from each other group (P<O.OOl, .04). Neutropenia was 
more prevalent in the ECB group (P=O.OOl), but 
neutropenia and hospitalization were more prolonged in 
the VREB group (P= .006, .006). Co-infection was more 
common in the VREB group (P<O.OOl). Twenty eight 
(32.9%) of patients were presented with septic shock in 
ECB group compared with 14.3% in VREB (P=O.O9). 
Acute mortality rate associated with ECB and VREB 
were 9.4% and 71.4% (PcO.001). Most E. coli isolates 
were susceptible to ceftazidime (lOO%), cefepime 
(100%) amikacin (94.1%) and at least one antibiotics 
used empirically were susceptible. But, 94.1% of E. coli 
were resistant to ciprofloxacin, the prophylactic 
antibiotics for gut decontamination. 
Conclusions: In spite of neutropenia and septic shock, 
most patients of ECB were recovered. Persistence of 
neutropenia, co-infection with fungus were associated 
with high mortality rate. 
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Background: This study was to investigate the etiologic 
organisms, risk factors, and other infectious features of 
septic shock in the hematology and oncology patients 
with neutropenic fever. 
Methods: We reviewed medical record of 671 patients 
receiving chemotherapy or hematopoietic stem cell trans- 
plantation (HSCT) at Catholic HSCT Center from Jan 
1998 to Dee 1999, and found out 457 patients developing 
neutropenic fever. Out of them, 39 patients developing 
septic shock as initial manifestation were enrolled into 
case group and age/sex matched 267 patients without 
hypotension were enrolled into control group. 
Results: There were 177 men and 129 women, with a 
median age of 31 years. Overall incidence of septic shock 
was 8.5%. Most common underlying disease of the two 
groups was acute leukemia. Infections were classified as 
31 MDI, 4 CDI, and 4 UF in the case group, whereas the 
control group had 105, 112,49, respectively (P<O.OOl). 
Thirty-seven microorganisms were isolated as causative 
agents in 31 MD1 of the case group. They were 5 gram- 
positive bacteria (13.5%) and 29 gram-negatives 
(78.3%). Whereas 137 microorganisms isolated in the 
MD1 of the control group were 63 gram-positive 
bacteria (45.9%) and 64 gram-negatives (46.7%). 
Relative risk for the gram-negative bacterial infection in 
the case group was 7.20 (P<O.OOl). Escherichia coli was 
the most common organism in the two groups (51.3% vs 
27.7%, P<O.OOl). Most common infection sites were 
respiratory tract in the case group and gastrointestinal 
tract in the control group. And the respiratory tract 
infection was significantly more frequent in the case 
group (P=O.O38). Mean leukocyte count at the onset of 
fever was 207/mm3 and 355/mm3 (P=O.O27) and mean 
duration of total febrile day was 12.3 days and 7.8 days, 
respectively (P=O.OOl). On multivariate analysis, only 
